Showing results (91-100 of 6,527) with videos related to
Sort By:
Pageof 653
The Journal of Steroid Biochemistry and Molecular Biology|October 1, 1990
Inhibitory effect of synthetic progestins, 4-MA and cyanoketone on human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene-isomerase activityM Takahashi, V Luu-The, F LabrieThe Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Human types 1 and 3 3 alpha-hydroxysteroid dehydrogenases: differential lability and tissue distributionI Dufort, F Labrie, V Luu-TheEndocrinology|January 1, 1981
Androgens decrease LHRH binding sites in rat anterior pituitary cells in cultureV Giguere, F A Lefebvre, F LabrieBiochemical and Biophysical Research Communications|October 14, 1983
Stimulation by prostaglandin F2 alpha of phosphatidic acid-phosphatidylinositol turnover in rat luteal cellsV Raymond, P C Leung, F LabrieInternational Journal of Fertility|January 1, 1980
Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in womenA Lemay, F Labrie, J P RaynaudThe Journal of Steroid Biochemistry and Molecular Biology|January 1, 1991
Differential inhibition of dehydrogenase and 5-ene----4-ene isomerase activities of purified 3 beta-hydroxysteroid dehydrogenase. Evidence for two distinct sitesV Luu-The, M Takahashi, F LabrieCurrent Medicinal Chemistry|January 19, 2000
Androgen receptor antagonists (antiandrogens): structure-activity relationshipsS M Singh, S Gauthier, F LabrieLife Sciences|December 27, 1982
Mechanism of action of TRH: involvement of the phosphatidylinositol (PI) response in the action of TRH in rat anterior pituitary cellsP C Leung, V Raymond, F LabrieBiology of Reproduction|April 1, 1982
Effects of chronic treatment with a potent luteinizing hormone releasing hormone agonist on serum luteinizing hormone and steroid levels in the male rhesus monkeyJ A Resko, A Belanger, F LabrieJournal of Medicinal Chemistry|March 31, 1995
Synthesis and in vitro activity of 17 beta-(N-alkyl/arylformamido)- and 17 beta-[(N-alkyl/aryl)alkyl/arylamido]-4-methyl-4-aza-3-oxo-5 alpha-androstan-3-ones as inhibitors of human 5 alpha-reductases and antagonists of the androgen receptorX Li, S M Singh, F LabriePageof 653